Advances in mRNA Vaccines for Infectious Diseases
- PMID: 30972078
- PMCID: PMC6446947
- DOI: 10.3389/fimmu.2019.00594
Advances in mRNA Vaccines for Infectious Diseases
Abstract
During the last two decades, there has been broad interest in RNA-based technologies for the development of prophylactic and therapeutic vaccines. Preclinical and clinical trials have shown that mRNA vaccines provide a safe and long-lasting immune response in animal models and humans. In this review, we summarize current research progress on mRNA vaccines, which have the potential to be quick-manufactured and to become powerful tools against infectious disease and we highlight the bright future of their design and applications.
Keywords: application; delivery; infectious disease; mRNA vaccine; mechanism.
Figures
Similar articles
-
mRNA vaccines against infectious diseases and future direction.Int Immunopharmacol. 2024 Jun 30;135:112320. doi: 10.1016/j.intimp.2024.112320. Epub 2024 May 24. Int Immunopharmacol. 2024. PMID: 38788451 Review.
-
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.Viruses. 2022 Feb 15;14(2):401. doi: 10.3390/v14020401. Viruses. 2022. PMID: 35215994 Free PMC article. Review.
-
mRNA vaccines for infectious diseases: principles, delivery and clinical translation.Nat Rev Drug Discov. 2021 Nov;20(11):817-838. doi: 10.1038/s41573-021-00283-5. Epub 2021 Aug 25. Nat Rev Drug Discov. 2021. PMID: 34433919 Free PMC article. Review.
-
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.Methods Mol Biol. 2021;2197:13-31. doi: 10.1007/978-1-0716-0872-2_2. Methods Mol Biol. 2021. PMID: 32827130 Review.
-
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.Mol Ther. 2019 Apr 10;27(4):757-772. doi: 10.1016/j.ymthe.2019.01.020. Epub 2019 Feb 7. Mol Ther. 2019. PMID: 30803823 Free PMC article. Review.
Cited by
-
Transient Aortitis after COVID-19 mRNA Vaccination.Mediterr J Rheumatol. 2023 Oct 20;35(1):195-196. doi: 10.31138/mjr.231020.nht. eCollection 2024 Mar. Mediterr J Rheumatol. 2023. PMID: 38736959 Free PMC article. No abstract available.
-
[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases].Open Respir Arch. 2021 Mar 22;3(2):100097. doi: 10.1016/j.opresp.2021.100097. eCollection 2021 Apr-Jun. Open Respir Arch. 2021. PMID: 38620748 Free PMC article. Spanish.
-
Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses.Vaccines (Basel). 2024 Mar 19;12(3):330. doi: 10.3390/vaccines12030330. Vaccines (Basel). 2024. PMID: 38543964 Free PMC article. Review.
-
Antibody Response after 3-Dose Booster against SARS-CoV-2 mRNA Vaccine in Kidney Transplant Recipients.Vaccines (Basel). 2024 Mar 1;12(3):264. doi: 10.3390/vaccines12030264. Vaccines (Basel). 2024. PMID: 38543898 Free PMC article.
-
Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models.medRxiv [Preprint]. 2024 Mar 7:2024.03.04.24303726. doi: 10.1101/2024.03.04.24303726. medRxiv. 2024. PMID: 38496570 Free PMC article. Preprint.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical